US EditionEssalud Confirms Supply of Tacrolimus and Distributes 129 Thousand Tablets to National Hospitals
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.3 Articles
3 Articles
Good news! Social Security has confirmed the supply of the drug "Tacrolimus", a vital drug for patients with organ transplants. Let’s remember that a few weeks ago both patients and family members reported to the MINSA a worrying shortage that put the health of these people at risk. YOU CAN SEE: Tacrolimus shortage in EsSalud alerts patients: what is it for and what people need it? EsSalud announces that Tacrolimus supply in health centers has b…
The Ombudsman monitors the measures taken by EsSalud and the Minsa in the face of the shortage of Tacrolimus medication and urges that it not be repeated.
The Social Health Insurance (EsSalud) reported this Saturday, that the crisis of supply of Tacrolimus is, for the time being, controlled, following the complaints made by patients and relatives who alerted about the lack of the medication in various establishments. According to the entity, this advance allows to reduce the risk of severe complications in transplanted persons, for whom the suspension of treatment can mean rejection of the organ o…
Coverage Details
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
